期刊文献+

α-细辛脑纳米粒离子敏感型鼻用原位凝胶的制备及体外释药性能 被引量:4

Preparation ofα-Asarone nanoparticle ion-sensitive in situ nasal gel and its drug releasing performance in vitro
原文传递
导出
摘要 目的:制备α-细辛脑纳米粒离子敏感型鼻用原位凝胶并考察其体外释放行为。方法:采用去乙酰结冷胶(DGG)为凝胶基质,以凝胶黏度,形成凝胶的能力及持水力为考察指标筛选去乙酰结冷胶的用量;采用纳米沉淀法制备α-细辛脑纳米粒,与凝胶基质混合后制得α-细辛脑纳米粒离子敏感型原位凝胶;以人工模拟鼻液为释放介质、考察制剂的体外释放特性。结果:确定0.5%的结冷胶作为α-细辛脑纳米粒离子敏感型原位凝胶的基质,在非生理状态为自由流动的液体,生理状态下能够发生相变形成凝胶。体外释放结果表明α-细辛脑纳米粒离子敏感型鼻用原位凝胶具有较好的缓释作用。结论:α-细辛脑纳米粒离子敏感型原位凝胶的胶凝效果良好,缓释作用明显且制备工艺简单可行。 OBJECTIVE To prepare ion-sensitive in situ nasal gel containingα-Asarone nanoparticles and study its in vitro release behavior.METHODS Gellan gum was used as gel matrix,and viscosity of in situ gel,ability to form gel and holding capacity were adopted as targets to select quantity of gellan gum.α-Asarone nanoparticles were prepared with nanoprecipitation method,and then were mixed with gellan gum to prepare nanoparticle ion-sensitive in situ gel.Simulated nasal fluid was applied as release medium to study in vitro release characteristics ofα-Asarone nanoparticle ion-sensitive in situ gel.RESULTS0.5% gellan gum was suitable toα-Asarone nanoparticles ion-sensitive in situ gel.It was semi-transparent fluid at non-physiological state,turned into semi-solid at physiological status.The in vitro study indicated thatα-Asarone nanoparticle ion-sensitive in situ gel possessed superior sustained-release effects.CONCLUSION α-Asarone nanoparticle ion-sensitive in situ gel has good gelatinizing effects,obvious sustaining effects,the preparing technique is simple and feasible.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第23期2115-2118,共4页 Chinese Journal of Hospital Pharmacy
基金 陕西省重点科技创新团队计划项目(编号:2012KCT-18)
关键词 Α-细辛脑 纳米粒 离子敏感原位凝胶 体外释放 α-Asarone nanoparticles ion-sensitive in situ gel drug release in vitro
作者简介 臧巧真,女,在读研究生。电话:029-87251837,E-mail:zan-gqiaozhen@163.com [通讯作者]李晔,女,研究员,研究方向:中药新型给药系统研究。电话:029-87251837,E-mail:liyelsj@163.com
  • 相关文献

参考文献15

  • 1杨云.中药化学成分提取分离手册[M].北京:中国中医药出版社,2001:349
  • 2赵李宏,吴建梅,武凤兰.α-细辛脑近10年研究概述[J].中国中药杂志,2007,32(7):562-565. 被引量:56
  • 3杨正鸿,吴闯.α-细辛脑在人体的生物利用度研究[J].中国医院药学杂志,1997,17(4):165-167. 被引量:29
  • 4Yu H, Kim K. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits[J]. Int J Pharm, 2009, 378(1-2):73-79.
  • 5Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs[J]. Int J Pharm, 2009, 379(1):146-157.
  • 6Cooper DL, Harirforoosh S. Design and optimization of PLGA based diclofenac loaded nanoparticles[J]. PloS One, 2014, 9(1):e87326.
  • 7Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance[J].Biomaterials, 2014, 35(7):2391-2400.
  • 8Ghasemian E, Vatanara A, Rouini MR, et al. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design[J].Daru, 2013, 21,(1):68.
  • 9Li JW, Feng L, Fan L, et al. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides[J]. Biomaterials,2011,32(21):4943-4950.
  • 10Ragelle H, Riva R, Vandermeulen G,et al. Chitosan nanoparticles for siRNA delivery:optimizing formulation to increase stability and efficiency[J]. J Control Release, 2014, 176:54-63.

二级参考文献73

共引文献118

同被引文献71

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部